Petmed Express sees $239,550 in stock purchases by major shareholders

Published 28/01/2025, 22:18
Petmed Express sees $239,550 in stock purchases by major shareholders

PetMed Express Inc. (NASDAQ:PETS) recently witnessed significant stock purchases by major shareholders. According to a recent SEC filing, Nina Capital Holdings Inc., along with Moises Tache Galante and Stephannie Matz Zyman, acquired a total of 50,000 shares of common stock, amounting to $239,550. The transactions occurred on January 24 and January 27, with purchase prices ranging from $4.635 to $4.947 per share. According to InvestingPro data, these purchases come as the stock has taken a significant 9.7% hit over the past week, while analysis suggests the stock is currently trading below its Fair Value.

The acquisitions have increased the shareholders’ total holdings to 2,225,000 shares. These shares are held by Nina Capital Holdings as well as jointly by Moises Tache Galante and Stephannie Matz Zyman. The purchases reflect continued investment interest in PetMed Express, a company based in Delray Beach, Florida, known for its retail operations in the drug store and proprietary store sector. The company maintains a strong balance sheet with more cash than debt and a healthy current ratio of 1.45, suggesting solid liquidity to meet its short-term obligations.

In other recent news, PetMed Express has been navigating through a series of significant developments. The company has adopted a limited duration shareholder rights plan, aimed at protecting the interests of all shareholders and preventing any entity from gaining disproportionate control. This strategic move is in response to the board’s view that the company’s stock is undervalued, not reflective of the business’s true worth or its future growth prospects.

In addition to this, PetMed Express has reported mixed results in its Q2 2025 earnings call. Despite a 16% drop in sales to $60 million, the company displayed resilience with a net income increase to $2.3 million, or $0.11 per diluted share. This performance was accompanied by the acquisition of approximately 77,000 new customers, attributed to operational improvements enhancing the customer service experience.

Furthermore, the company has outlined plans for a significant marketing push during the holiday season to further boost customer acquisition. PetMed Express is also preparing to launch a new content site, as part of its efforts to become a leader in consumer pet healthcare. Despite challenges, including a projected decrease in margins due to increased promotional activities in Q3, the company’s focus on customer acquisition and operational efficiency underscores its commitment to navigating the current market landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.